Status:
COMPLETED
LSA4 Protocol for the Treatment of Advanced Pediatric and Adolescent Non-Hodgkins Lymphoma
Lead Sponsor:
Memorial Sloan Kettering Cancer Center
Conditions:
Non-Hodgkin's Lymphoma
Eligibility:
All Genders
Up to 21 years
Phase:
PHASE2
Brief Summary
Non-Hodgin's lymphoma is curable in 76% of patients. In nonlymphoblastic lymphmas, cancer may return on average 3 months from beginning treatment and for lymphoblastic lymphomas, 6 months. To aggressi...
Eligibility Criteria
Inclusion
- Non-Hodgkin's Lymphoma stages III, IV, IVA with
- T cell lymphomas, any primary site irrespective of LDH level
- large cell lymphomas, any primary site irrespective of LDH level
- B cell lymphomas, any primary site with initial LDH of less than 500
Exclusion
- B cell lymphomas, any primary site with initial LDH of less than 500 and initial CNS or bone involvement
Key Trial Info
Start Date :
May 1 1990
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 1 2008
Estimated Enrollment :
17 Patients enrolled
Trial Details
Trial ID
NCT00610883
Start Date
May 1 1990
End Date
December 1 2008
Last Update
September 28 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Memorial Sloan-Kettering Cancer Center
New York, New York, United States, 10065